Flexion Therapeutics is committed to helping the more than 15 million Americans with osteoarthritis, despite treatment of the degenerative musculoskeletal disorder at a relative standstill, with short-term pain management with steroid injections considered standard care. The company developed triamcinolone acetonide extended-release injectable suspension (Zilretta), which was approved by the FDA in 2017, that resulted in […]

Aduhelm demonstrated a consistent treatment effect for slowing decline in cognitive, functional and behavioral domains among patients with early Alzheimer’s disease in item-level analysis of the phase 3 EMERGE study. Results from this analysis demonstrated consistency with results from the primary analysis of clinical endpoints for Aduhelm (aducanumab, Biogen/Eisai), according to the study results. Researchers […]

Jim Joyce is the Co-Founder, Chairman, and CEO of Sigyn Therapeutics, and we talk about removing inflammatory targets from the bloodstream with advanced blood purification technology. Jim says, “The next transformative step in the recipe of blood purification is the advancement of devices that can address the sources of inflammation, which could be a viral or […]